Moreover, we noticed that BTLA and CTLA-4 gene polymorphisms are associated with mRNA expression and that variations in their genes might be considered as potential CLL risk factors [21, 22]. The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.